Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Lymphocytic Leucemia”

5 trials

Showing 5 of 5 results

Testing effectiveness (Phase 2)UnknownNCT02320383
What this trial is testing

CLLR3: Bendamustine + GA101 (BG) in Relapsed or Refractory CLL Followed by GA101 Maintenance for Responding Patients

Who this might be right for
Chronic Lymphocytic Leucemia
Munich Municipal Hospital 27
Testing effectiveness (Phase 2)Study completedNCT02445131
What this trial is testing

Sequential Regimen of Bendamustine-Debulking Followed by CAL-101 and GA101-Induction and -Maintenance in CLL (CLL2-BCG)

Who this might be right for
Chronic Lymphocytic Leucemia
German CLL Study Group 48
Testing effectiveness (Phase 2)Study completedNCT02345863
What this trial is testing

Sequential Regimen of Bendamustin [B] Followed by GA101 and Ibrutinib [I] in CLL Patients

Who this might be right for
Chronic Lymphocytic Leucemia
German CLL Study Group 66
Testing effectiveness (Phase 2)Study completedNCT02401503
What this trial is testing

Sequential Regimen of Bendamustine-Debulking Followed by ABT-199 and GA101-Induction and -Maintenance in CLL (CLL2-BAG)

Who this might be right for
Chronic Lymphocytic Leucemia
German CLL Study Group 66
Not applicableLooking for participantsNCT07313982
What this trial is testing

LEF1 EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A MARKER FOR DIAGNOSIS AND SURVIVAL PREDICTION

Who this might be right for
Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 350

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation